James Melhorn

6PUBLICATIONS
25CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMedical bacteriologyGene expression (incl. microarray and other genome-wide approaches)Human biophysicsNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 09, 2025
Fractional exhaled nitric oxide and the response to prednisolone for asthma attacks in patients treated with anti-IL5/5Rα therapy: a prospective observational study.

Imran Howell, Mahdi Mahdi, Hafiz R Mahmood

|Dec 18, 2024
Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment.

Gabriel Lavoie, Imran Howell, James Melhorn

|Jul 11, 2024
Uncontrolled mild-to-moderate asthma may not be mild or moderate, or even asthma: The benefits of early phenotyping.

James Melhorn, Gabriel Lavoie

|Jun 23, 2023
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST).

Imran Howell, Mahdi Mahdi, Mona Bafadhel

|Feb 11, 2022
Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? The results of the UK POETIC survey.

James Melhorn, Andrew Achaiah, Francesca M Conway

|Aug 07, 2021
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide.

Simon Couillard, Annette Laugerud, Maisha Jabeen

Pageof 1

Frequent Collaborators

3 joint publications

Maisha Jabeen

3 joint publications

Sanjay Ramakrishnan

3 joint publications

Timothy S C Hinks

3 joint publications

Ian Pavord